Enzo Biochem's Q1 Revenues Rise 8 Percent on Biomol Contribution | GenomeWeb
NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Thursday that its first-quarter 2009 revenues increased around 8 percent due to the contribution of Biomol, which Enzo acquired earlier this year for $18 million plus earn-outs over the next two years.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.